Skip to content

Clinical trials

Phase 3 Tobacco Use Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tobacco Use Disorder Phase: Phase 3 Country / region: United States Clear all

45 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20021
20032
20041
20053
20062
20072
20083
20091
20105
20115
20123
20133
20141
20151
20161
20171
20181
20191
20201
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Recruiting3
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of California, San Francisco6
Mayo Clinic5
National Institute on Drug Abuse (NIDA)3
University of California, San Diego3
University of Pennsylvania3
Butler Hospital2
Duke University2
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.2
Medical University of South Carolina2
UConn Health2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tobacco Use Disorder45
Acquired Immunodeficiency Syndrome2
Alcoholism1
Body Weight1
Cocaine-Related Disorders1
HIV Infections1
Major Depressive Disorder1
Marijuana Use1
Neoplasms1
Pulmonary Disease, Chronic Obstructive1

Trials

Showing 1 to 25 of 45. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.